Skip to main contentSkip to navigation
Sirius Investors
H. Lundbeck A/S

H. Lundbeck A/S

HLBBF
OTCHealthcare

H. Lundbeck A/S (HLBBF) Financial Metrics

This dashboard provides comprehensive financial metrics and analysis to help evaluate H. Lundbeck A/S's investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.

Financial Metrics Score

Valuation Metrics

Sector benchmarks: Industrials

2025
P/E Ratio
13.40
Strong
WeakModerateStrong
P/B Ratio
1.72
Strong
WeakModerateStrong
Earnings Yield
7.45%
Strong
WeakModerateStrong

Profitability Health

2025
Return on Equity
12.82%
Moderate
WeakModerateStrong
Operating Margin
26.05%
Strong
WeakModerateStrong
Net Profit Margin
13.11%
Moderate
WeakModerateStrong

Growth Indicators

2025
Revenue Growth
10.42%
Strong
WeakModerateStrong
Net Income Growth
1.33%
Weak
WeakModerateStrong
EPS Growth
1.26%
Weak
WeakModerateStrong

Efficiency & Liquidity

2025
Current Ratio
1.44
Moderate
WeakModerateStrong
Quick Ratio
0.94
Weak
WeakModerateStrong
Asset Turnover
0.45x
Weak
WeakModerateStrong
Inventory Turnover
1.11x
Weak
WeakModerateStrong

Cash Flow & Resilience

Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes

2025
Free Cash Flow Yield
10.14%
Strong
WeakModerateStrong
EV / Free Cash Flow
11.84x
Strong
WeakModerateStrong
Net Debt / EBITDA
1.17x
Moderate
WeakModerateStrong
Interest Burden (EBT / EBIT)
0.707
Weak
WeakModerateStrong
Return on Invested Capital
9.98%
Weak
WeakModerateStrong
Cash Conversion Cycle
54.26 days
Weak
WeakModerateStrong

Fortress screener guardrails

2/4 passing
  • FCF Yield > 3%
  • Net Debt / EBITDA < 1.5x
  • ROIC > 20%
  • Cash Conversion Cycle < 0 days

Financial Statements

Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for HLBBF.

View Financial Statements